MedTrace Logo

Recurrent Neovascular Age-related Macular Degeneration After Therapy Suspension

NCT04659512 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 105

Last updated 2020-12-10

No results posted yet for this study

Summary

The purpose of this study is to investigate prospectively the recurrence rate of active macular neovascularization (MNV) and the visual outcome in patients with nAMD previously on a Treat and Extend regimen where treatment has been discontinued due to disease stability.

Conditions

  • Age-related Macular Degeneration

Sponsors & Collaborators

  • St. Erik Eye Hospital

    lead OTHER

Principal Investigators

  • David Epstein · Sankt Erik Eye Hospital

Eligibility

Min Age
55 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2017-10-01
Primary Completion
2019-02-28
Completion
2020-06-06

Countries

  • Sweden

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04659512 on ClinicalTrials.gov